1. Chaves JC, Neto FS, Ikejiri AT, Bertoletto PR, Teruya R, Santos Simoes R, et al. Period of hyperbaric oxygen delivery leads to different degrees of hepatic ischemia/reperfusion injury in rats. Transplant Proc 2016; 48:516-520.
2. Tao X, Wan X, Xu Y, Xu L, Qi Y, Yin L, et al. Dioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation, and apoptosis. Transplantation 2014; 98:604-611.
3. Xue L, Wu Z, Ji XP, Gao XQ, Guo YH. Effect and mechanism of salvianolic acid B on the myocardial ischemia-reperfusion injury in rats. Asian Pac J Trop Med 2014; 7:280-284.
4. Cai X, Wang X, Li J, Chen S. Protective effect of glycyrrhizin on myocardial ischemia/reperfusion injury-induced oxidative stress, inducible nitric oxide synthase and inflammatory reactions through high-mobility group box 1 and mitogen-activated protein kinase expression. Exp Ther Med 2017; 14:1219-1226.
5. Gong G, Xiang L, Yuan L, Hu L, Wu W, Cai L, et al. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS One 2014; 9:e89450.
6. Ni B, Cao Z, Liu Y. Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia-reperfusion injury. Int J Neurosci 2013; 123:745-751.
7. Wang Y, Chen Q, Shi C, Jiao F, Gong Z. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol Med Rep 2019; 20:4081-4090.
8. Yan T, Wang H, Zhao M, Yagai T, Chai Y, Krausz KW, et al. Glycyrrhizin protects against acetaminophen-induced acute liver injury via alleviating tumor necrosis factor alpha-mediated apoptosis. Drug Metab Dispos 2016; 44:720-731.
9. Hua S, Ma M, Fei X, Zhang Y, Gong F, Fang M. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis. Int Immunopharmacol 2019; 68:145-155.
10. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55:1265-1272.
11. Zhang Q, Lai Y, Deng J, Wang M, Wang Z, Wang M, et al. Vagus nerve stimulation attenuates hepatic ischemia/reperfusion injury via the Nrf2/HO-1 Pathway. Oxid Med Cell Longev 2019; 2019:9549506.
12. Zhao Y, Cai H, Zhou P, Lin S, Pan Y, Liang X. Protective effect of ulinastatin on hepatic ischemia reperfusion injury through autophagy activation in Chang liver cells. J Cell Biochem 2019; 120:14960-14970.
13. Sehitoglu I, Tumkaya L, Bedir R, Kalkan Y, Cure MC, Yucel AF, et al. Zoledronic acid aggravates kidney damage during ischemia reperfusion injury in rat. J Environ Pathol Toxicol Oncol 2015; 34:53-61.
14. Ye Z, Chen O, Zhang R, Nakao A, Fan D, Zhang T, et al. Methane attenuates hepatic ischemia/reperfusion injury in rats through antiapoptotic, anti-inflammatory, and antioxidative actions. Shock 2015; 44:181-187.
15. Tao YE, Wen Z, Song Y, Wang H. Paeoniflorin attenuates hepatic ischemia/reperfusion injury via anti-oxidative, anti-inflammatory and anti-apoptotic pathways. Exp Ther Med 2016; 11:263-268.
16. Zhang CB, Tang YC, Xu XJ, Guo SX, Wang HZ. Hydrogen gas inhalation protects against liver ischemia/reperfusion injury by activating the NF-kappa B signaling pathway. Exp Ther Med 2015; 9:2114-2120.
17. Deng J, Feng J, Liu T, Lu X, Wang W, Liu N, et al. Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways. Drug Des Devel Ther 2018; 12:4067-4082.
18. Cursio R, Colosetti P, Gugenheim J. Autophagy and liver ischemia-reperfusion injury. Biomed Res Int 2015; 2015:417590.
19. Ye S, Zhu Y, Ming Y, She X, Liu H, Ye Q. Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling. Exp Ther Med 2014; 7:1247-1252.
20. Fei L, Jifeng F, Tiantian W, Yi H, Linghui P. Glycyrrhizin ameliorate ischemia reperfusion lung injury through down-regulate TLR2 signaling cascade in alveolar macrophages. Front Pharmacol 2017; 8:389.
21. Sil R, Ray D, Chakraborti AS. Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model. Mol Cell Biochem 2015; 409:177-189.
22. Ikeda T, Abe K, Kuroda N, Kida Y, Inoue H, Wake K, et al. The inhibition of apoptosis by glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide / D-galactosamine in mice. Arch Histol Cytol 2008; 71:163-178.
23. Wang Y, Wang Q, Zhang L, Ke Z, Zhao Y, Wang D, et al. Coptisine protects cardiomyocyte against hypoxia/reoxygenation-induced damage via inhibition of autophagy. Biochem Biophys Res Commun 2017; 490:231-238.
24. Qi L, Sun X, Li FE, Zhu BS, Braun FK, Liu ZQ, et al. HMGB1 promotes mitochondrial dysfunction-triggered striatal neurodegeneration via autophagy and apoptosis activation. PLoS One 2015; 10:e0142901.
25. Hu T, Wei G, Xi M, Yan J, Wu X, Wang Y, et al. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway. Int J Mol Med 2016; 38:83-94.
26. Chai J, Luo L, Hou F, Fan X, Yu J, Ma W, et al. Agmatine reduces lipopolysaccharide-mediated oxidant response via activating PI3K/Akt pathway and up-regulating Nrf2 and HO-1 expression in macrophages. PLoS One 2016; 11:e0163634.
27. Gu L, Ye P, Li H, Wang Y, Xu Y, Tian Q, et al. Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE(-/-) mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway. FASEB J 2019; 33:4836-4850.
28. He M, Pan H, Chang RC, So KF, Brecha NC, Pu M. Activation of the Nrf2/HO-1 anti-oxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage. PLoS One 2014; 9:e84800.
29. Kim YM, Kim HJ, Chang KC. Glycyrrhizin reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and endotoxemic mice by p38/Nrf2-dependent induction of HO-1. Int Immunopharmacol 2015; 26:112-118.